4th Department of Internal Medicine, Infectious Disease Laboratory, Molecular Biology Section, Athens University School of Medicine, Chaidari, Greece.
Clin Microbiol Infect. 2012 Mar;18(3):E52-4. doi: 10.1111/j.1469-0691.2011.03738.x. Epub 2012 Jan 20.
16S ribosomal RNA methylase-mediated high-level resistance to 4-,6-aminoglycosides has been reported in clinical isolates of gram-negative bacilli from several countries. Three of 1534 (0.2%) isolates of Klebsiella pneumoniae and three of 734 (0.4%) Proteus mirabilis isolates from a university hospital in Athens, Greece, were positive for rmtB and highly resistant to all aminoglycosides tested (MICs ≥256 mg/L). Two of the K. pneumoniae rmtB-bearing isolates, were KPC-2 and OXA-10 producers and the third was a DHA-1 producer. One of the P. mirabilis isolates was a VIM-1 and OXA-10 producer and one was an OXA-10 producer. All rmtB-harbouring isolates were clonally unrelated. None of the E. coli (n = 1398) and Enterobacter spp. (n = 414) isolates were positive for armA, rmtA, rmtB, rmtC or rmtD.
16S 核糖体 RNA 甲基酶介导的对 4-、6-氨基糖苷类的高水平耐药性已在来自多个国家的革兰氏阴性杆菌临床分离株中报道。在希腊雅典一所大学医院的 1534 株(0.2%)肺炎克雷伯菌和 734 株(0.4%)奇异变形杆菌分离株中,有 3 株 rmtB 阳性且对所有测试的氨基糖苷类药物高度耐药(MICs≥256mg/L)。携带 rmtB 的 2 株肺炎克雷伯菌分离株为 KPC-2 和 OXA-10 产酶株,第 3 株为 DHA-1 产酶株。1 株奇异变形杆菌分离株为 VIM-1 和 OXA-10 产酶株,1 株为 OXA-10 产酶株。所有携带 rmtB 的分离株均无克隆相关性。在 1398 株大肠埃希菌和 414 株肠杆菌属分离株中,均未检测到 armA、rmtA、rmtB、rmtC 或 rmtD。